This profile was last updated on //
Is this you? Claim your profile.
(48 Total References)
"The results of BIOSOLVE-II confirm that ...
"The results of BIOSOLVE-II confirm that the BIOTRONIK Magnesium Scaffold is both a safe and effective option for treating coronary artery disease (CAD), and establish it as the first clinically-proven magnesium-based bioresorbable scaffold," commented principal investigator of the study Dr. Michael Haude of the Lukaskrankenhaus, Neuss, Germany.
It is based on a natural element widely present in the human body, and the magnesium-based properties promote a faster and simpler implantation procedure," commented Dr. Haude
This analysis takes the next step ...
This analysis takes the next step in projecting that these benefits result in the cost effectiveness of the therapy," said Michael Haude, M.D. PhD, Chief of Cardiology at Lukaskrankenhaus in Neuss, Germany and co-author of the study.
"Late stent thrombosis is still a ...
"Late stent thrombosis is still a concern for patients treated with monotherapy DES, leaving them dependent on a minimum of six months DAPT," said Michael Haude , M.D., director of Medical Clinic I at the Lukaskrankenhaus in Neuss, Germany, and principal investigator of the REMEDEE trial.
The dual therapy stent was shown ...
The dual therapy stent was shown to be safe and effective, as well as non-inferior to the paclitaxel-eluting stent, according to lead researcher Michael Haude, Professor of Internal Medicine at Lukaskrankenhaus Neuss in Germany.
Results of the REMEDEE trial were presented at the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
Visit Cardiology page.
europcr.com - Board Members